Previous Article | Next Article ![]()
Infection and Immunity, April 1999, p. 1606-1613, Vol. 67, No. 4
Department of Medical Microbiology,
University of Manitoba, Winnipeg, Canada
Received 2 October 1998/Returned for modification 17 November
1998/Accepted 13 January 1999
As is true for other intracellular pathogens, immunization with
live Chlamydia trachomatis generally induces stronger
protective immunity than does immunization with inactivated organism.
To investigate the basis for such a difference, we studied immune responses in BALB/c mice immunized with viable or UV-killed C. trachomatis mouse pneumonitis (MoPn). Strong, acquired resistance to C. trachomatis infection was elicited by immunization
with viable but not dead organisms. Immunization with viable organisms induced high levels of antigen-specific delayed-type hypersensitivity (DTH), gamma interferon production, and immunoglobulin A (IgA) responses. Immunization with inactivated MoPn mainly induced
interleukin-10 (IL-10) production and IgG1 antibody without IgA or DTH
responses. Analysis of local early cytokine and cellular events at days
3, 5, and 7 after peritoneal cavity immunization showed that high levels of granulocyte-macrophage colony-stimulating factor and IL-12
were detected with viable but not inactivated organisms. Furthermore,
enrichment of a dendritic cell (DC)-like population was detected in the
peritoneal cavity only among mice immunized with viable organisms. The
results suggest that early differences in inducing proinflammatory
cytokines and activation and differentiation of DCs may be the key
mechanism underlying the difference between viable and inactivated
organisms in inducing active immunity to C. trachomatis infection.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Immunity to Chlamydia trachomatis Mouse Pneumonitis
Induced by Vaccination with Live Organisms Correlates with
Early Granulocyte-Macrophage Colony-Stimulating Factor and
Interleukin-12 Production and with Dendritic Cell-Like
Maturation
*
Corresponding author. Mailing address: Department of
Medical Microbiology, University of Manitoba, 543-730 William Ave.,
Winnipeg, Manitoba R3E OW3, Canada. Phone: (204) 789-3524. Fax: (204)
789-3926. E-mail: Robert_Brunham{at}UManitoba.CA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|